-+ 0.00%
-+ 0.00%
-+ 0.00%

HLB raises HLB Therapeutics stake to 20.05% from 19.92% via open-market buys

PUBT·10/02/2026 02:02:45
Listen to the news
HLB raises HLB Therapeutics stake to 20.05% from 19.92% via open-market buys
  • HLB raised its stake in HLB Therapeutics to 19,308,381 shares, or 20.05%, from 19,177,797 shares, or 19.92%.
  • The increase reflected open-market purchases by a related party, with the change-trigger date set at Oct. 1, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HLB Therapeutics Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261002000098), on October 02, 2026, and is solely responsible for the information contained therein.